Research ArticleClinical Studies
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI and ICHIRO IEIRI
Anticancer Research April 2022, 42 (4) 2053-2060; DOI: https://doi.org/10.21873/anticanres.15686
MAYAKO UCHIDA
1Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan;
2Department of Education and Research Center for Pharmacy Practice, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts, Kyoto, Japan;
SAEKO MURATA
2Department of Education and Research Center for Pharmacy Practice, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts, Kyoto, Japan;
HANAE MORIKAWA
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
HIROKO YONEMITSU
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
SHIGERU ISHIDA
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
KIMITAKA SUETSUGU
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
TOSHIKAZU TSUJI
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
HIROYUKI WATANABE
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
4Department of Pharmacy, Fukuoka Tokushukai Hospital, Fukuoka, Japan;
TAKEHIRO KAWASHIRI
5Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan;
KOJI KATO
6Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
KEIKO HOSOHATA
1Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan;
TOSHIHIRO MIYAMOTO
6Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
NOBUAKI EGASHIRA
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
TSUTOMU NAKAMURA
1Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan;
KOICHI AKASHI
6Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
ICHIRO IEIRI
3Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan;
This article has a correction. Please see:
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI, ICHIRO IEIRI
Anticancer Research Apr 2022, 42 (4) 2053-2060; DOI: 10.21873/anticanres.15686
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI, ICHIRO IEIRI
Anticancer Research Apr 2022, 42 (4) 2053-2060; DOI: 10.21873/anticanres.15686
Jump to section
Related Articles
Cited By...
- Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data
- Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia